Pemigatinib in the Treatment of Metastatic, Inflammatory Triple-Negative Breast Cancer WithFGFR2Rearrangement: A Case Report and Review of the Literature

发表于 7 天前

期刊：JCO Precision Oncology

文献作者：Nihaal Reddy; Katarina Vasiljevic; Rebecca Shatsky

出版日期：2026-8-

DOI号：10.1200/po-25-00628

下载链接：https://ascopubs.org/doi/pdfdirect/10.1200/PO-25-00628

文献链接：https://doi.org/10.1200/po-25-00628

当前文献来源于 American Society of Clinical Oncology (ASCO)。

备注信息：

发表于 7 天前

: 当前求助已完成，请重新发起求助。
已完结状态的附件将会在24小时内删除。

[ASCO] Pemigatinib in the Treatment of Metastatic, Inflammatory Triple-Negative Breast Cancer WithFGFR2Rearrangement: A Case Report and Review of the Literature

已采纳

同分类求助

最新回复

站点公告

今日热心研友

（热心研友QQ群）

[ASCO] Pemigatinib in the Treatment of Metastatic, Inflammatory Triple-Negative Breast Cancer WithFGFR2Rearrangement: A Case Report and Review of the Literature 一键复制